| Company Name: | VISX, Incorporated | | Ticker Symbol: | EYE | | | WWW Address: | www.visx.com | | CEO: | Elizabeth H. Davila | | No. of Employees: | 352 | | Common Issue Type: | CS | | Business Description: | Worldwide developer of proprietary technologies and systems for laser vision correction. The Company's main system is the VISX Excimer Laser System(TM).
|
| | | Industry Information: | HEALTH SERVICES - Medical Appliances & Equipment [more like this]Company Name: | Advanced Medical Optics Incorporated | | Ticker Symbol: | EYE | | | WWW Address: | www.amo-inc.com | | CEO: | James V. Mazzo | | No. of Employees: | 3,711 | | Common Issue Type: | CS | | Business Description: | The Company develops, manufactures and markets medical devices for the eyes. It has three product lines: cataract, refractive and eye care.
|
| | | Industry Information: | HEALTH SERVICES - Medical Instruments & Supplies [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 21.98 |  0.0 | - | - | 0 | 24.75 | 24.44 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 1,101.2 | 50.1 | 1.60 | 0.76 | 0.00 | 30.2 | 0.0 | 27.95 - 15.50 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 21.98 | $ | | PE Ratio - LTM | 22.7 | |
| Market Capitalisation | 1,347.0 | mil |
| Latest Shares Outstanding | 61.3 | mil |
| Earnings pS (EPS) | 0.97 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 319,330 | $ |
| Effective Tax Rate | 18.7 | % |
| Float | 60.9 | mil |
| Float as % of Shares Outstanding | 99.4 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 42.00 | % |
| Research & Devlopment (R&D) as % of Revenue | 6.40 | % |
| Gross Profit Margin | 60.5 | % |
| EBITDA Margin | 12.0 | % |
| Pre-Tax Profit Margin | 6.3 | % |
| Assets Turnover | 0.4 | % |
| Return on Assets (ROA) | 2.4 | % |
| Return on Equity (ROE) | 9.5 | % |
| Return on Capital Invested (ROCI) | 3.2 | % |
| Current Ratio | 1.5 | |
| Leverage Ratio (Assets/Equity) | 4.0 | |
| Interest Cover | 2.0 | |
| Total Debt/Equity (Gearing Ratio) | 2.21 | |
| LT Debt/Total Capital | 67.0 | % |
| Working Capital pS | 2.84 | $ |
| Cash pS | 0.83 | $ |
| Book-Value pS | 10.44 | $ |
| Tangible Book-Value pS | -18.20 | $ |
| Cash Flow pS | 2.87 | $ |
| Free Cash Flow pS | 1.70 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.11 | |
| Price/Tangible Book Ratio | -1.21 | |
| Price/Cash Flow | 7.7 | |
| Price/Free Cash Flow | 12.9 | |
| P/E as % of Industry Group | 145.0 | % |
| P/E as % of Sector Segment | 104.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.2 | 103 | 15,972 | 64,691 |
| 4 Weeks | 22.04 | 21.79 | 21.97 | 0.0 | 110 | 20,018 | 360,324 |
| 13 Weeks | 22.04 | 4.86 | 5.81 | 278.3 | 450 | 36,306 | 2,178,347 |
| 26 Weeks | 23.63 | 2.88 | 21.63 | 1.6 | 173 | 25,387 | 3,122,638 |
| 52 Weeks | 24.90 | 2.88 | 22.88 | -3.9 | 170 | 16,656 | 4,163,925 |
| YTD | 22.04 | 6.35 | - | 232.5 | 399 | 52,893 | 2,009,939 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 21.98 | 21.96 | 15.85 | 14.13 | 16.07 | -0.10 | -0.29 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 14.13 | 94.5 | 8.84 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 12.20 | NA | -4.53 |
| R&D | 16.54 | NA | 8.74 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 8.6 | -6.4 | 8.6 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 4.19 | 0.59 | 4.19 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 6.88 |
| Current Ratio | 1.5 |
| Quick Ratio (Acid Test) | 0.8 |
| Liquidity Ratio (Cash) | 0.14 |
| Receivables Turnover | 4.7 |
| Average Collection Period | 77 |
| Working Capital/Equity | 27.3 |
| Working Capital pS | 2.82 |
| Cash-Flow pS | 2.84 |
| Free Cash-Flow pS | 1.68 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 1.24 |
| Financial Leverage Ratio (Assets/Equity) | 4.0 |
| Debt Ratio | 74.7 |
| Total Debt/Equity (Gearing Ratio) | 2.21 |
| LT Debt/Equity | 2.02 |
| LT Debt/Capital Invested | 79.8 |
| LT Debt/Total Liabilities | 68.3 |
| Interest Cover | 2.0 |
| Interest/Capital Invested | 3.55 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 32.68 |
| Tobin's Q Ratio | 0.53 |
| Current P/E Ratio - LTM | 22.70 |
| Enterprise Value (EV)/EBITDA | 22.36 |
| Enterprise Value (EV)/Free Cash Flow | 23.88 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -1.21 |
| Price/Book Ratio - LTM | 2.11 |
| Price/Cash Flow Ratio | 7.7 |
| Price/Free Cash Flow Ratio - LTM | 12.9 |
| Price/Sales Ratio | 1.14 |
| P/E Ratio (1 month ago) - LTM | 22.5 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 145.0 |
| P/E as % of Sector Segment | 104.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 40.0 |
| PER SHARE FIGURES |
| LT Debt pS | 20.94 |
| Current Liabilities pS | 5.66 |
| Tangible Book Value pS - LTM | -18.20 |
| Book Value pS - LTM | 10.44 |
| Capital Invested pS | 31.55 |
| Cash pS - LTM | 0.83 |
| Cash Flow pS - LTM | 2.87 |
| Free Cash Flow pS - LTM | 1.70 |
| Earnings pS (EPS) | 0.97 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 8.77 |
| Free Cash Flow Margin 5YEAR AVG | -21.33 |
| Net Profit Margin | 5.1 |
| Net Profit Margin - 5YEAR AVRG. | -12.9 |
| Equity Productivity | 1.85 |
| Return on Equity (ROE) | 9.5 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 0.61 |
| Return on Capital Invested (ROCI) | 3.2 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -8.0 |
| Assets Productivity | 0.40 |
| Return on Assets (ROA) | 2.4 |
| Return on Assets (ROA) - 5YEAR AVRG. | -6.1 |
| Gross Profit Margin | 60.5 |
| Gross Profit Margin - 5YEAR AVRG. | 65.4 |
| EBITDA Margin - LTM | 12.0 |
| EBIT Margin - LTM | 12.9 |
| Pre-Tax Profit Margin | 6.3 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -10.6 |
| Effective Tax Rate | 18.7 |
| Effective Tax Rate - 5YEAR AVRG. | 9.4 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 202 |
| Revenue per Employee | 319,330 |
| Net Income per Employee | 16,444 |
| Average Collection Period | 73 |
| Receivables Turnover | 4.7 |
| Day's Inventory Turnover Ratio | 129 |
| Inventory Turnover | 2.8 |
| Inventory/Sales | 14.8 |
| Accounts Payble/Sales | 3.98 |
| Assets/Revenue | 2.50 |
| Net Working Capital Turnover | 6.80 |
| Fixed Assets Turnover | 0.59 |
| Total Assets Turnover | 0.4 |
| Revenue per $ Cash | 23.37 |
| Revenue per $ Plant | 7.29 |
| Revenue per $ Common Equity | 1.85 |
| Revenue per $ Capital Invested | 0.61 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 42.0 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 44.1 |
| Research & Devlopment (R&D) as % of Revenue | 6.4 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 6.4 |
|
|  
|
| |
 |  |